DEVICE · Unmapped registry intervention
OculusGen Biodegradable Collagen Matrix Implant
Find medicine records ·
Find other trials using this name
Clinical trial
Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Zhong-Shan Hospital
NCT00320957
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedOlogen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Zhong-Shan Hospital
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Glaucomasunresolved
Pterygiumverified · MONDO: pterygium
Interventions
Sponsors & collaborators
Pro Top & Mediking Company Limitedlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00320957 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.